Coherus BioSciences to Report Fourth Quarter and Full Year 2020 Financial Results on February 24th

Rhea-AI Summary

Coherus BioSciences (CHRS) will announce its fourth quarter and full year 2020 financial results on February 24, 2021, after market close. The company will host an investor conference call at 4:30 p.m. ET to discuss its financial performance and corporate updates. Interested participants can join via telephone or webcast. Coherus is focused on providing cost-effective medicines to improve patient access and reduce healthcare costs.

News Market Reaction – CHRS

-2.78%

-2.78% Session move

In the trading session that priced this news, CHRS declined 2.78%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or “the Company”, Nasdaq: CHRS), today announced that it will release fourth quarter and full year 2020 financial results after the market closes on Wednesday, February 24, 2021. The news release will be followed by an investor conference call at 4:30 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the Company will review its financial results and provide a corporate update.

Conference Call Information

When: Wednesday, February 24, 2021 starting at 4:30 p.m. ET
Dial-in: (844) 452-6826 (toll free) or (765) 507-2587 (International)
Conference ID: 3770488
Webcast: https://investors.coherus.com/upcoming-events

Please join the conference call at least 10 minutes early to register. The webcast will be archived on the Coherus website.

About Coherus BioSciences

Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system.

For additional information, please visit www.coherus.com.

Contact
McDavid Stilwell
EVP, Financial Strategy and IR
Coherus BioSciences, Inc.
mstilwell@coherus.com
+1 (650) 395-0152

FAQ

What are the financial results of Coherus BioSciences for Q4 2020?

Coherus BioSciences will release its Q4 2020 financial results on February 24, 2021.

When is the Coherus BioSciences investor conference call?

The conference call is scheduled for February 24, 2021, at 4:30 p.m. ET.

How can I join the Coherus BioSciences conference call?

You can join the call by dialing (844) 452-6826 within the U.S. or (765) 507-2587 internationally.

What is the purpose of Coherus BioSciences' upcoming conference call?

The call will cover the company's financial results and provide a corporate update.